ImmuneXcite's Debt - II Round

ImmuneXcite raised a round of funding on February 01, 2017.

ImmuneXcite has developed a platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets.…

Articles about ImmuneXcite's Debt - II Round: